Last Two Of Three Big Inclisiran Studies Boosts The Medicines Co.

 
• By Mandy Jackson
  
GoldKeyInPuzzle_1200x675
The Medicines Co. unlocked the last two sets of Phase III data for inclisiran. • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D